Market Place
Sourcing Support
Prostact Global Phase 3 Chosen For Late-Breaking ASCO 2026
21 Apr 2026 //
GLOBENEWSWIRE
Telix Refinances Convertible Bonds
14 Apr 2026 //
PR NEWSWIRE
Telix And Regeneron Announce Strategic Radiopharma Collaboration
13 Apr 2026 //
GLOBENEWSWIRE
Telix Strengthens Board With Additional Director Appointments
08 Apr 2026 //
GLOBENEWSWIRE
Telix Resubmits Tlx101-Px NDA For Pixclara Brain Cancer Imaging
15 Mar 2026 //
GLOBENEWSWIRE
Investor Education Webinar
01 Mar 2026 //
GLOBENEWSWIRE
Company Reports Strong Commercial Growth & Focused Pipeline
19 Feb 2026 //
GLOBENEWSWIRE
Telix 2025 Full-Year Results Investor Webcast Notification
03 Feb 2026 //
GLOBENEWSWIRE
Telix Hits FY25 Targets: $804M Revenue, Gozellix Launch
20 Jan 2026 //
GLOBENEWSWIRE
Telix To Showcase Pipeline & Commercial Portfolio At Morgan Conf
08 Jan 2026 //
GLOBENEWSWIRE
Telix, Varian Announce Theranostics-EBRT Clinical Collaboration
10 Dec 2025 //
GLOBENEWSWIRE
Robbins LLP Informs Telix Pharma Shareholders Of TLX Class Action
28 Nov 2025 //
PR NEWSWIRE
Telix To Present at UBS & Jefferies Global Healthcare Conferences
05 Nov 2025 //
GLOBENEWSWIRE
Telix Reports US$206M Revenue, FY 2025 Guidance Upgraded
14 Oct 2025 //
GLOBENEWSWIRE
CMS Grants Transitional Pass-Through Status for Gozellix
23 Sep 2025 //
GLOBENEWSWIRE
Telix Begins Phase 3 BiPASS Trial: PSMA-PET for Prostate Cancer
09 Sep 2025 //
GLOBENEWSWIRE
Telix to Present at Global Healthcare and Investment Conferences
26 Aug 2025 //
GLOBENEWSWIRE
Telix 2025 Half-Year Results Show Strong Performance
20 Aug 2025 //
GLOBENEWSWIRE
Telix H1 2025 Results: Webcast Notice for Investors
29 Jul 2025 //
GLOBENEWSWIRE
Telix`s Revenue Rises 63% YOY to $204M
22 Jul 2025 //
GLOBENEWSWIRE
Gozellix Granted Permanent HCPCS Code
09 Jul 2025 //
GLOBENEWSWIRE
Illuccix Approved in US for Patient Selection for Pre-Taxane RLT
23 Jun 2025 //
GLOBENEWSWIRE
Telix Precision Announces AlFluor Radiochemistry Platform
20 Jun 2025 //
GLOBENEWSWIRE
Telix Theranostic Programs and Satellite Symposia at SNMMI 2025
19 Jun 2025 //
GLOBENEWSWIRE
Telix Launches Prostate Cancer Imaging Agent Gozellix in US
11 Jun 2025 //
GLOBENEWSWIRE
Telix`s Illuccix PSMA-PET Imaging Agent Approved in Germany
05 Jun 2025 //
PR NEWSWIRE
Telix Investor Day in NYC on June 11, 2025: Presenting KOLs
03 Jun 2025 //
GLOBENEWSWIRE
Telix to Host Investor Day in New York City on June 11, 2025
22 May 2025 //
GLOBENEWSWIRE
Telix Reports US$186M Q1 Revenue, Up 62% YOY
22 Apr 2025 //
GLOBENEWSWIRE
IPAX-Linz Study Shows TLX101`s Efficacy for Glioma Therapy
15 Apr 2025 //
GLOBENEWSWIRE
Telix partners with Cardinal Health for Gozellix distribution
08 Apr 2025 //
GLOBENEWSWIRE
Telix Appoints Paul Schaffer as Chief Technology Officer
07 Apr 2025 //
GLOBENEWSWIRE
Anne Whitaker Appointed as Non-Executive Director
03 Apr 2025 //
GLOBENEWSWIRE
ARTMS Drug Master File for Gallium Production Technology Referenced
01 Apr 2025 //
GLOBENEWSWIRE
Telix Doses First Patient in ZOLAR Trial of TLX300-CDx in Sarcoma
01 Apr 2025 //
GLOBENEWSWIRE
Telix Adds Lead-212 Isotope Production Capability
12 Mar 2025 //
GLOBENEWSWIRE
Telix Therapeutics Urology Showcase and Expert Forum
03 Mar 2025 //
GLOBENEWSWIRE
Miami Phase 3 Trial of Prostate Cancer Radiopharmaceutical Begins
25 Feb 2025 //
GLOBENEWSWIRE
Telix Posts Record 2024 Performance, Sets FY2025 Guidance At $1.23B
20 Feb 2025 //
GLOBENEWSWIRE
Telix Reports Record FY24 Results, FY25 Guidance Up To $1.23B
20 Feb 2025 //
PR NEWSWIRE
Telix To Showcase Urology Pipeline At ASCO GU 2025
13 Feb 2025 //
GLOBENEWSWIRE
Illuccix® Approved in the United Kingdom
12 Feb 2025 //
GLOBENEWSWIRE
Telix Completes Acquisition of RLS (USA)
27 Jan 2025 //
GLOBENEWSWIRE
Illuccix Receives European Approval
17 Jan 2025 //
GLOBENEWSWIRE
Telix Exceeds FY24 Guidance with US$142M Q4 Revenue
13 Jan 2025 //
GLOBENEWSWIRE
Telix Presentation to Annual J.P. Morgan Healthcare Conference
13 Jan 2025 //
GLOBENEWSWIRE
Scintimun Commercial Partnership with Curium Pharma
13 Jan 2025 //
PR NEWSWIRE
Businessperson of the year 2024- Dr Christian (Telix Pharma)
02 Jan 2025 //
BIOSPACE
Telix Completes Cyclotron Installation at Brussels South Facility
19 Dec 2024 //
PR NEWSWIRE
Telix Manufacturing, Brussel South Complete Cyclotron Installation
19 Dec 2024 //
GLOBENEWSWIRE
Telix to Add FAP-Targeting Candidates to Theranostic Pipeline
18 Nov 2024 //
PR NEWSWIRE
Telix & Eckert & Ziegler to Partner on Actinium-225 Technology
13 Nov 2024 //
GLOBENEWSWIRE
Telix ADSs Commence Trading on Nasdaq
13 Nov 2024 //
GLOBENEWSWIRE
FDA Accepts TLX101-CDx New Drug Application for Brain Cancer
23 Oct 2024 //
GLOBENEWSWIRE
Telix Spins Off Rhine To Expand Access To Radiopharmaceuticals
22 Oct 2024 //
PR NEWSWIRE
After buyouts, Telix unveils new radiopharma spinoff Rhine
22 Oct 2024 //
FIERCE PHARMA
Telix Q3 2024 Business Update – Quarterly Revenue Exceeds AU$200M
17 Oct 2024 //
GLOBENEWSWIRE
Telix Files Form 20-F Registration Statement for Nasdaq ADS
17 Oct 2024 //
GLOBENEWSWIRE
Telix Featured In 13 Abstracts At EANM Annual Congress
16 Oct 2024 //
PR NEWSWIRE
Health Canada Approves Label Expansion For Telix`s Illuccix
04 Oct 2024 //
GLOBENEWSWIRE
